N/A
Manufactured by Biogen Inc.
25,327 FDA adverse event reports analyzed
Last updated: 2026-04-14
DIROXIMEL FUMARATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Biogen Inc.. The most commonly reported adverse reactions for DIROXIMEL FUMARATE include FLUSHING, MULTIPLE SCLEROSIS, MULTIPLE SCLEROSIS RELAPSE, DIARRHOEA, PRODUCT DOSE OMISSION ISSUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIROXIMEL FUMARATE.
Out of 11,105 classified reports for DIROXIMEL FUMARATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 25,327 FDA FAERS reports that mention DIROXIMEL FUMARATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FLUSHING, MULTIPLE SCLEROSIS, MULTIPLE SCLEROSIS RELAPSE, DIARRHOEA, PRODUCT DOSE OMISSION ISSUE, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Biogen Inc. in connection with DIROXIMEL FUMARATE. Always verify the specific product and NDC with your pharmacist.